Rfp Financial Group LLC Amgen Inc Transaction History

Rfp Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $525 - $638	-2 Reduced 0.91%	217 $67,000
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $8,603 - $10,385	32 Added 17.11%	219 $62,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $15,853 - $17,884	62 Added 49.6%	187 $53,000
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $2,623 - $3,257	-12 Reduced 8.76%	125 $33,000
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $2,571 - $3,040	12 Added 9.6%	137 $30,000
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $28,628 - $36,376	125 New	125 $32.8 Million

3,082

417M

7.24M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.